Evidence map›Paper›PMID 33672357›Full record

ArticleInternational journal of molecular sciences2021

KRAS

George Kyriakopoulos, Vicky Katopodi, Ilias Skeparnias, Eleni G Kaliatsi, Katerina Grafanaki, Constantinos Stathopoulos

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

George KyriakopoulosDepartment of Biochemistry, School of Medicine, University of Patras, 26504 Patras, Greece;g.kyriakopoulos@upnet.gr (G.K.).ORCID 0000-0002-5628-6138
Vicky KatopodiDepartment of Biochemistry, School of Medicine, University of Patras, 26504 Patras, Greece;g.kyriakopoulos@upnet.gr (G.K.).ORCID 0000-0002-4336-7107
Ilias SkeparniasDepartment of Biochemistry, School of Medicine, University of Patras, 26504 Patras, Greece;g.kyriakopoulos@upnet.gr (G.K.).
Eleni G KaliatsiDepartment of Biochemistry, School of Medicine, University of Patras, 26504 Patras, Greece;g.kyriakopoulos@upnet.gr (G.K.).ORCID 0000-0001-5397-3445
Katerina GrafanakiDepartment of Biochemistry, School of Medicine, University of Patras, 26504 Patras, Greece;g.kyriakopoulos@upnet.gr (G.K.).
Constantinos StathopoulosDepartment of Biochemistry, School of Medicine, University of Patras, 26504 Patras, Greece;g.kyriakopoulos@upnet.gr (G.K.).ORCID 0000-0002-5699-4118
University of Patras · GR

Funding

INSPIRED-The National Research Infrastructures on Integrated Structural Biology, Drug Screening Efforts and Drug target functional characterization MIS 5002550
6 · The paper itself

Abstract

KRAS

Indexed as

A549 CellsAdenocarcinoma of LungCell Line, TumorCodon, InitiatorErbB ReceptorsEukaryotic Initiation Factor-4FHumansLung NeoplasmsMutationPhosphatidylinositol 3-KinasesPhosphorylationProtein BiosynthesisProto-Oncogene Proteins c-aktProto-Oncogene Proteins p21(ras)RNA CapsTOR Serine-Threonine KinasesCodon, InitiatorEGFR protein, humanErbB ReceptorsEukaryotic Initiation Factor-4FKRAS protein, humanMTOR protein, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktProto-Oncogene Proteins p21(ras)RNA CapsTOR Serine-Threonine KinasesTranscription Activator-Like Effector NucleasesKRASG12Clung cancersignal transductiontranslation initiation

Identifiers

PMID33672357
PMCPMC7926983
OpenAlexW3130776790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.